FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Saco de Visser

Research Profile

Procedures

Concepts & Ideas

Disorders

Physiology

Chemicals & Drugs

Co-author Network

Publications

TOP 3
M Liem-Moolenaar; F A Gray; Saco J de Visser; K L Franson; Rik C Schoemaker; J A J Schmitt; Adam Cohen; J M A van Gerven
Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol.
S L de Haas; Saco J de Visser; Jeroen-Paul van der Post; Rik C Schoemaker; Kristien van Dyck; M Gail Murphy; Marina De Smet; L K Vessey; R Ramakrishnan; L Xue; Adam Cohen; J M A van Gerven
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
S L de Haas; Saco J de Visser; Jeroen-Paul van der Post; M de Smet; Rik C Schoemaker; B Rijnbeek; Adam Cohen; Jose M Vega; Nancy G B Agrawal; Thanh V Goel; Richard C Simpson; L K Pearson; S Li; Michael Hesney; M Gail Murphy; J M A van Gerven
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Saco de Visser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: M Liem-Moolenaar; F A Gray; Saco J de Visser; K L Franson; Rik C Schoemaker; J A J Schmitt; Adam Cohen; J M A van Gerven
Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol.
Journal of psychopharmacology (Oxford, England) 2010;24(1):73-82.
2008: S L de Haas; Saco J de Visser; Jeroen-Paul van der Post; Rik C Schoemaker; Kristien van Dyck; M Gail Murphy; Marina De Smet; L K Vessey; R Ramakrishnan; L Xue; Adam Cohen; J M A van Gerven
Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers.
Journal of psychopharmacology (Oxford, England) 2008;22(1):24-32.
2007: S L de Haas; Saco J de Visser; Jeroen-Paul van der Post; M de Smet; Rik C Schoemaker; B Rijnbeek; Adam Cohen; Jose M Vega; Nancy G B Agrawal; Thanh V Goel; Richard C Simpson; L K Pearson; S Li; Michael Hesney; M Gail Murphy; J M A van Gerven
Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
Journal of psychopharmacology (Oxford, England) 2007;21(4):374-83.
2005: Jeroen-Paul van der Post; Saco J de Visser; Marieke L de Kam; M Woelfler; Dana C Hilt; James J Vornov; Eric Burak; Enoch Bortey; Barbara Slusher; T Limsakun; Adam Cohen; J M A van Gerven
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693.
British journal of clinical pharmacology 2005;60(2):128-36.
2005: G J H Dumont; Saco J de Visser; Adam Cohen; J M A van Gerven
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.
British journal of clinical pharmacology 2005;59(5):495-510.
2004: Jeroen-Paul van der Post; Saco J de Visser; Rik C Schoemaker; Adam Cohen; J M A van Gerven
Pharmacokinetic/pharmacodynamic assessment of tolerance to central nervous system effects of a 3 mg sustained release tablet of rilmenidine in hypertensive patients.
Journal of psychopharmacology (Oxford, England) 2004;18(2):221-7.
2003: B Rijnbeek; Saco J de Visser; K L Franson; Adam Cohen; J M A van Gerven
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers.
Journal of psychopharmacology (Oxford, England) 2003;17(2):196-203.
2003: Saco J de Visser; Jeroen-Paul van der Post; P P de Waal; F Cornet; Adam Cohen; J M A van Gerven
Biomarkers for the effects of benzodiazepines in healthy volunteers.
British journal of clinical pharmacology 2003;55(1):39-50.
2002: Saco J de Visser; Jeroen-Paul van der Post; Loyd Nanhekhan; Rik C Schoemaker; Adam Cohen; J M A van Gerven
Concentration-effect relationships of two rilmenidine single-dose infusion rates in hypertensive patients.
Clinical pharmacology and therapeutics 2002;72(4):419-28.
2001: Saco J de Visser; J M A van Gerven; Rik C Schoemaker; Adam Cohen
Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects.
British journal of clinical pharmacology 2001;51(5):423-8.
2001: Saco J de Visser; Jeroen-Paul van der Post; Monique S M Pieters; Adam Cohen; J M A van Gerven
Biomarkers for the effects of antipsychotic drugs in healthy volunteers.
British journal of clinical pharmacology 2001;51(2):119-32.
2001: Robbert J Verkes; Harm J Gijsman; Monique S M Pieters; Rik C Schoemaker; Saco J de Visser; M Kuijpers; Ed J M Pennings; D de Bruin; G Van de Wijngaart; J M A van Gerven; Adam Cohen
Cognitive performance and serotonergic function in users of ecstasy.
Psychopharmacology 2001;153(2):196-202.
1998: J M A van Gerven; E Uchida; N Uchida; Monique S M Pieters; A J Meinders; Rik C Schoemaker; L V Nanhekhan; J M Kroon; Saco J de Visser; B Altorf; K Yasuda; H Yasuhara; Adam Cohen
Pharmacodynamics and pharmacokinetics of a single oral dose of nitrazepam in healthy volunteers: an interethnic comparative study between Japanese and European volunteers.
Journal of clinical pharmacology 1998;38(12):1129-36.